Regenerative Labs produces regenerative medicine products to address the root cause of a patient’s conditions using Wharton’s Jelly innovations rather than masking the pain with other treatments. Regenative Labs works closely with scientists, physicians, hospitals, and surgery centers to constantly monitor and improve patient progress and outcomes for new product development. Formed by veteran industry professionals familiar with daily challenges of innovations in healthcare, the company provides effective, non-addictive, non-invasive options for patients. Regenative Labs has a laser-focused, exper product research and development team which follows FDA guidelines of minimal manipulation for homologous use. The company adheres to AATB and FDA guidelines.
Regenative Lab’s mission is to facilitate predictable patient outcomes by providing the highest quality human tissue allografts available. With the goal of addressing the root cause, rather than masking the pain, Regenative Labs birth tissue allografts provide a non-addictive, non-invasive option for patients. Our first-class, state-of-the-art production facility is located in Pensacola, Florida. We spare no expense when it comes to the technology that we all insist is necessary to produce the quality regenerative products we expect for our partners.
